Response of bone turnover markers to bisphosphonate treatment in Paget's disease.

被引：0
|
作者：
Gill, KA [1 ]
Naylor, KE [1 ]
Ellison, JV [1 ]
Bainbridge, PR [1 ]
Eastell, R [1 ]
机构：
[1] Univ Sheffield, Div Clin Sci, Bone Metab Grp, Sheffield S10 2TN, S Yorkshire, England
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P52
引用
收藏
页码：1050 / 1050
页数：1
相关论文
共 50 条
  • [41] Effects of RANK-Ligand Antibody (Denosumab) Treatment on Bone Turnover Markers in a Girl With Juvenile Paget's Disease
    Grasemann, Corinna
    Schuendeln, Michael M.
    Hoevel, Matthias
    Schweiger, Bernd
    Bergmann, Christoph
    Herrmann, Ralf
    Wieczorek, Dagmar
    Zabel, Bernhard
    Wieland, Regina
    Hauffa, Berthold P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (08): : 3121 - 3126
  • [42] Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity
    Alvarez, L
    Peris, P
    Pons, F
    Guanabens, N
    Herranz, R
    Monegal, A
    Bedini, JL
    Deulofeu, R
    deOsaba, MJM
    MunozGomez, J
    Ballesta, AM
    ARTHRITIS AND RHEUMATISM, 1997, 40 (03): : 461 - 468
  • [43] Randomized Trial of Intensive Bisphosphonate Treatment Versus Symptomatic Management in Paget's Disease of Bone
    Langston, Anne L.
    Campbell, Marion K.
    Fraser, William D.
    MacLennan, Graeme S.
    Selby, Peter L.
    Ralston, Stuart H.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (01) : 20 - 31
  • [44] A randomised trial of intensive bisphosphonate therapy versus symptomatic treatment for Paget's disease of bone
    Langston, A. L.
    Fraser, W. D.
    Selby, P. L.
    Campbe, M. K.
    MacLennan, G.
    Ralston, S. H.
    BONE, 2007, 40 (06) : S161 - S161
  • [45] Treatment of Paget's disease of bone
    Lojo Oliveira, Leticia
    Torrijos Eslava, Antonio
    REUMATOLOGIA CLINICA, 2012, 8 (04): : 220 - 224
  • [46] Treatment of Paget's Disease of Bone
    Urteaga, Elizabeth M.
    US PHARMACIST, 2012, 37 (10) : 29 - 34
  • [47] Treatment of Paget's disease of bone
    Arias M, Garcia
    Eslava A, Torrijos
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2011, 3 (01) : 35 - 40
  • [48] DIFFERENT RESPONSES OF BIOCHEMICAL MARKERS OF BONE-RESORPTION TO BISPHOSPHONATE THERAPY IN PAGET DISEASE
    BLUMSOHN, A
    NAYLOR, KE
    ASSIRI, AMA
    EASTELL, R
    CLINICAL CHEMISTRY, 1995, 41 (11) : 1592 - 1598
  • [49] Bisphosphonate (olpadronate) retention and its determinants in Paget's disease of bone
    Cremers, SCLM
    Eekhoff, E
    van Dam, SM
    Hartigh, J
    Hamdy, NAT
    Vermeij, P
    Papapoulos, SE
    BONE, 2001, 28 (05) : S127 - S127
  • [50] Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone
    Merlotti, Daniela
    Gennari, Luigi
    Martini, Giuseppe
    Valleggi, Fabrizio
    De Paola, Vincenzo
    Avanzati, Annalisa
    Nuti, Ranuccio
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (10) : 1510 - 1517
12345